Vaccine News and Research

Latest Vaccine News and Research

FDA approves second COVID-19 booster dose for older and immunocompromised individuals

FDA approves second COVID-19 booster dose for older and immunocompromised individuals

Government provides new guidance for living with COVID

Government provides new guidance for living with COVID

Study provides further assurances about the safety of COVID-19 vaccination during pregnancy

Study provides further assurances about the safety of COVID-19 vaccination during pregnancy

Study shows potential inhibition of SARS-CoV-2 main protease by natural phytochemicals

Study shows potential inhibition of SARS-CoV-2 main protease by natural phytochemicals

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

Study explores the waning efficacy of SARS-CoV-2 ChAdOx1 and BNT162b2 vaccines

Study explores the waning efficacy of SARS-CoV-2 ChAdOx1 and BNT162b2 vaccines

Immune response dynamics following COVID-19 heterologous and homologous vaccinations

Immune response dynamics following COVID-19 heterologous and homologous vaccinations

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

New compound delivered in a nasal spray effectively treats delta variant infection in mice

New compound delivered in a nasal spray effectively treats delta variant infection in mice

Is COVID-19 vaccination during pregnancy safe?

Is COVID-19 vaccination during pregnancy safe?

One year after severe COVID-19, T cells persist against SARS-CoV-2

One year after severe COVID-19, T cells persist against SARS-CoV-2

Virtual reality helps reduce COVID-19 vaccine hesitancy

Virtual reality helps reduce COVID-19 vaccine hesitancy

Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

Hybrid immunity and booster vaccination provides best protection against SARS-CoV-2 BA.1 and BA.2

Hybrid immunity and booster vaccination provides best protection against SARS-CoV-2 BA.1 and BA.2

Risk of death from SARS-CoV-2 infection higher than after COVID vaccination

Risk of death from SARS-CoV-2 infection higher than after COVID vaccination

COVID-19 vaccination continues to protect adults against severe illness and death

COVID-19 vaccination continues to protect adults against severe illness and death

Dynamics of SARS-CoV-2 viral load in vaccinated and recovered individuals

Dynamics of SARS-CoV-2 viral load in vaccinated and recovered individuals

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.